Literature DB >> 19916056

First report of Tritirachium oryzae infection of human scalp.

R N R Moraes1, M C T Ribeiro, M C L Nogueira, K C Cunha, M M C N Soares, M T G Almeida.   

Abstract

The natural habitat of Tritirachium oryzae is soil and decaying plant material. It is also an insect pathogen. As a human pathogen, it has been reported as a cause of corneal ulcers and otomycosis. The case of a 4-year-old infant is reported with Tritirachium oryzae infection of the scalp. Diagnosis was established by direct mycological study and culture that showed Tritirachium oryzae as the only agent in a pure culture. The topical treatment involved an antifungal medication to a complete cure. We report the first case of scalp dermatomycosis due to Tritirachium oryzae infection, illustrating a novel clinical manifestation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19916056     DOI: 10.1007/s11046-009-9253-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  1 in total

1.  Exogenous corneal ulcer caused by Tritirachium roseum.

Authors:  M M Rodrigues; P Laibson
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

  1 in total
  3 in total

1.  Distal Lateral Subungual Onychomycosis Owing to Tritirachium oryzae: A Bystander or Invader?

Authors:  Hari Pankaj Vanam; P Narsimha Rao; Kalyani Mohanram; Prakash Peralam Yegneswaran; Shiva Prakash Mandya Rudramurthy
Journal:  Mycopathologia       Date:  2017-11-21       Impact factor: 2.574

2.  First case of Tritirachium oryzae as agent of onychomycosis and its susceptibility to antifungal drugs.

Authors:  Ali Naseri; Abdolmajid Fata; Mohammad Javad Najafzadeh
Journal:  Mycopathologia       Date:  2013-04-17       Impact factor: 2.574

3.  Isolation and molecular identification of keratinophilic fungi from public parks soil in Shiraz, Iran.

Authors:  Keyvan Pakshir; Moosa Rahimi Ghiasi; Kamiar Zomorodian; Ali Reza Gharavi
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.